Fabio Pulighe

Robotic Technology (United States)

Papers

2

Total Citations

57

H-Index

2

About

Dr. Fabio Pulighe is a surgeon whose research focuses on advancing minimally-invasive techniques for complex gastrointestinal and vascular conditions. His work spans the optimization of surgical timing in oncology and the application of robotic platforms to rare anatomical disorders. A key contribution is his leadership in the TiMiSNAR trial, a multicenter randomized controlled study investigating the optimal interval (8 vs. 12 weeks) between neoadjuvant chemoradiotherapy and minimally-invasive surgery for rectal cancer, addressing a critical debate in oncologic timing to maximize pathological complete response. Dr. Pulighe has also pioneered the robotic-assisted approach for Median Arcuate Ligament Syndrome (MALS), notably in patients with variant anatomy such as a left gastric artery originating directly from the aorta. His 2018 case report and literature review, which has garnered 43 citations, demonstrated the safety and feasibility of robotic MAL release, offering a less invasive alternative for this rare condition. By combining rigorous trial methodology with innovative surgical applications, Dr. Pulighe’s work directly impacts clinical decision-making and expands the boundaries of what is achievable with robotic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
57
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Robotic‐assisted approach to Median Arcuate Ligament Syndrome with left gastric artery originating directly from the aorta. Report of a case and review of the current mini‐invasive treatment modalities
43 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Robotic Technology (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago